Home

Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 23/09/05

Trade details

Type
Insider sale
Amount
$6,722.47
Shares · price
457 sh · $14.71 a share
Held after
50,574 sh
Trade date
23/09/05
Filed
23/09/05
Days to filing
0 days

Sold 0.9% of holdings

Share of holding sold
0.9%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/06~23/10/05

Christopher R. Cline's recent trades

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $3.3M

    Filed 09/15

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $101.7K

    Filed 05/06

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned saleTravere Therapeutics

    $101.7K

    Filed 05/05